Ursin G, Peters R K, Henderson B E, d'Ablaing G, Monroe K R, Pike M C
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90033-9987.
Lancet. 1994 Nov 19;344(8934):1390-4. doi: 10.1016/s0140-6736(94)90567-3.
The incidence of adenocarcinoma of the cervix in the USA more than doubled between the early 1970s and the mid 1980s among women under 35 years of age. It was suggested that this increase was due to the introduction of oral contraceptives in the early 1960s. Adenocarcinoma of the cervix diagnosed in women born after 1935 was identified between 1977 and 1991 from the Los Angeles County Cancer Surveillance Program. Data from personal interviews of 195 cases and 386 controls (matched on age, race, and neighbourhood) were analysed. Information on medical, sexual, contraceptive, and reproductive history, previous cervical smears, and sexually transmitted diseases was collected. Compared with never use, ever use of oral contraceptives was associated with twice as great a risk of adenocarcinoma of the cervix (adjusted odds ratio 2.1, 95% CI 1.1-3.8). The highest risk was observed for oral contraceptive use for more than 12 years (4.4, 1.8-10.8). No additional increased risk was found for early age at start of oral contraceptive use, use before age 20 or before first pregnancy, time since first use, time since last use, or particular formulations, once total duration of use had been accounted for.
20世纪70年代初至80年代中期,美国35岁以下女性宫颈癌腺癌的发病率增加了一倍多。有人认为,这种增加是由于20世纪60年代初引入了口服避孕药。1977年至1991年期间,从洛杉矶县癌症监测项目中确定了1935年以后出生的女性中诊断出的宫颈癌腺癌。分析了对195例病例和386名对照(按年龄、种族和邻里匹配)进行个人访谈的数据。收集了有关医疗、性、避孕和生殖史、以前的宫颈涂片检查以及性传播疾病的信息。与从未使用过口服避孕药相比,曾经使用过口服避孕药的女性患宫颈癌腺癌的风险高出两倍(调整后的优势比为2.1,95%可信区间为1.1-3.8)。口服避孕药使用超过12年的风险最高(4.4,1.8-10.8)。在考虑了口服避孕药的总使用时长后,未发现开始使用口服避孕药的年龄较早、20岁之前或首次怀孕之前使用、首次使用以来的时间、最后一次使用以来的时间或特定配方会增加额外风险。